Susan Hasty, Publisher
Table of Contents . . . January 24th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Immunotherapy Weekly | Other Publications
Conjunctivitis - Tests Reveal Allergy or Non-Specific Causes
Anaphylaxis - T Cells Involved in Pathogenesis
Asthma - Do Glucocorticoids Increase Intraocular Pressure?
Asthma - Lycopene Protects Against Exercise-Induced Symptoms
Raynaud's Phenomenon - Anti-Centromere Antibodies May Act as Disease Markers
Cancer Studies - Phase II Study Can Begin in Mexico
Drug Development - Collaboration Established to Accelerate Antibody Research
Immune Thrombocytopenic Purpura - Phase II Study of Humanized Antibody Initiated
Psoriasis - Phase IIb ABX-IL8 Study to Proceed
Radioimmunotherapy - Ibritumomab Tiuxetan Under Evaluation for Lymphatic Cancers
Sjogren's Syndrome - Phase III Completion of Clinical Trial Announced
AIDS Therapies - Immunotherapy Added to First Cycle of Antiviral Cocktails
Asthma - Chinese Herbal Medicine May Be Useful in Treatment
Asthma - Fluticasone Effective for Function, Symptoms, Quality of Life
Asthma - Less Dry Powder Fluticasone for More Relief
Cardiopulmonary Bypass - Phase IIb TP10 Study Begins in Infants Undergoing High Risk Cardiac Surgery
Interferon Therapy - Treatment in Hepatitis C Patients Associated with Brain Hypometabolism
Mycobacterial Infections - Actimmune Phase II Trial Initiated to Treat Atypical Disease
Ovarian Cancer - Favorable OvaRex Phase II Trial Results Reported
Rheumatoid Arthritis - FDA Approves Remicade with Methotrexate as First Drug to Inhibit Progression of Joint Damage
Stem Cell Transplantation - Home-Treated Patients Improve Faster than Those Hospital-Bound
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.